Coherus Oncology, Inc.
CHRS
$1.13
-$0.04-3.42%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 237.64M | 82.41M | 125.99M | 97.69M | 159.24M |
Total Receivables | 119.64M | 62.44M | 122.33M | 198.80M | 313.57M |
Inventory | 4.51M | 3.52M | 70.09M | 47.64M | 62.16M |
Prepaid Expenses | 18.42M | 22.84M | 23.17M | 24.89M | 22.96M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 138.97M | -- | -- | -- |
Total Current Assets | 380.21M | 310.18M | 341.58M | 369.02M | 557.93M |
|
|||||
Total Current Assets | 380.21M | 310.18M | 341.58M | 369.02M | 557.93M |
Net Property, Plant & Equipment | 1.91M | 2.26M | 7.36M | 2.91M | 3.33M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 52.31M | 52.98M | 53.65M | 54.31M | 55.46M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 5.04M | 5.66M | 45.95M | 78.75M | 58.14M |
Total Assets | 439.46M | 371.07M | 448.53M | 505.00M | 674.86M |
|
|||||
Total Accounts Payable | 37.62M | 40.93M | 28.46M | 21.89M | 76.82M |
Total Accrued Expenses | 120.25M | 185.96M | 227.04M | 227.03M | 239.33M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.76M | 1.80M | 2.84M | 3.81M | 4.12M |
Total Finance Division Other Current Liabilities | 104.00M | 26.36M | 24.65M | 42.84M | 142.74M |
Total Other Current Liabilities | 104.00M | 26.36M | 24.65M | 42.84M | 142.74M |
Total Current Liabilities | 263.63M | 255.04M | 282.98M | 295.57M | 463.01M |
|
|||||
Total Current Liabilities | 263.63M | 255.04M | 282.98M | 295.57M | 463.01M |
Long-Term Debt | 36.87M | 294.85M | 292.52M | 291.94M | 290.06M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.41M | 2.85M | 3.29M | 3.74M | 4.17M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 16.74M | 1.79M | 1.73M | 1.73M | 1.73M |
Total Liabilities | 319.64M | 554.54M | 580.52M | 592.97M | 758.96M |
|
|||||
Common Stock & APIC | 1.43B | 1.42B | 1.42B | 1.41B | 1.41B |
Retained Earnings | -1.31B | -1.61B | -1.55B | -1.50B | -1.49B |
Treasury Stock & Other | -275.00K | -275.00K | -275.00K | -275.00K | -272.00K |
Total Common Equity | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 119.83M | -183.47M | -131.99M | -87.97M | -84.11M |
|